Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

AngioScore brings in $30mm through its Series E round

Executive Summary

AngioScore (angioplasty catheters) has raised $30mm through the closing of its Series E venture round. Telegraph Hill Partners led the financing and was joined by all of the company's current institutional investors including Psilos Group Managers, QuestMark Partners, UV Partners, California Technology Ventures, and InnoMed Ventures. Thomas Weisel was the placement agent.

Deal Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies